Philippines parallel trade drug lobby row

25 March 2007

The alleged attempts by drug firm lobbyists to "interfere" with a debate in the Philippines' House of Representatives over the Cheaper Medicine Act 2007, which includes the authorization for parallel drug trading, has provoked a furore. Four representatives of the Pharmaceutical and Healthcare Association of the Philippines were ejected from the congressional chamber for supposedly asking for a Representative to challenge the meeting's quorum, in order to prevent a vote from being taken. Equivalent legislation has been approved in the Senate (Marketletter February 5) and the final law would be drafted by a bicameral conference committee before a final vote in both chambers of Congress later this year.

The contents of a note, allegedly written by one of the lobbyists to Rep Teodoro Locsin (Makati), were published by several media outlets and includes a request to telephone Leo Wassmer, the PHAP's chief executive, with his mobile telephone number. The PHAP issued a statement insisting that the attempt to contact Rep Locsin was simply because he represents the group's local congressional district.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight